Sharemaestro Newsreel

Tactile Medical projects $360M-$366M 2026 revenue as airway clearance ordering normalizes in Q4

Earnings Call Insights: Tactile Systems Technology (TCMD) Q2 2026 MANAGEMENT VIEW * "We delivered another strong quarter of execution in Q2, highlighted by continued strength in our lymphedema business and meaningful profitability expansion." (CEO, President & Director Sheri Dodd) * "Based on our first …

Adapthealth director Dale Wolf buys $244,600 in company stock

Dale B. Wolf, a director at AdaptHealth Corp. (NASDAQ:AHCO), recently purchased 40,000 shares of company stock for $244,600 in early August 2026, with prices between $5.83 and $6.37 per share. These insider purchases occurred while AHCO shares traded near their 52-week low, and InvestingPro …

Is Globus Medical (GMED) Cheap After Its Earnings Beat And Higher EPS Outlook?

Globus Medical (GMED) has seen positive momentum with a 7.39% 90-day share price return following an earnings beat and higher EPS outlook. Despite a year-to-date dip, its 1-year total shareholder return is 40.41%. A valuation narrative suggests the stock is 23.3% undervalued, with a …

CCORF Maintains Orthofix Medical(OFIX.US) With Buy Rating, Cuts Target Price to $13

CCORF has reiterated its Buy rating for Orthofix Medical (OFIX.US) but has lowered its target price to $13. This indicates a continued positive outlook on the company despite a revised valuation.

Inspire Medical Systems (INSP) Q2 2026 Earnings Call Transcript

Image source: The Motley Fool. DATE Monday, Aug. 3, 2026 at 5:00 p.m. ET CALL PARTICIPANTS Vice President of Investor Relations - Ezgi YagciChairman and Chief Executive Officer - Tim HerbertChief Financial Officer - Matt Osberg TAKEAWAYS Revenue -- $200.6 million for the second …

ClearPoint Neuro (CLPT) Q2 2026 Earnings Call Transcript

Stronger Q2 Results and Higher 2026 Outlook Might Change The Case For Investing In DexCom (DXCM)

DexCom (DXCM) reported stronger-than-expected Q2 2026 results with increased sales and net income, and raised its full-year 2026 revenue guidance. This positive performance reinforces management's confidence in the demand for its continuous glucose monitoring systems and supports the adoption-driven catalyst investors are watching. Despite …

AdaptHealth (NASDAQ:AHCO) Director Purchases $149,930.00 in Stock

AdaptHealth (NASDAQ:AHCO) Director Kenneth Samet recently purchased 23,500 shares for $149,930, increasing his stake by 93.74%. Despite the purchase and analysts' "Moderate Buy" rating with a $10.29 price target, the stock fell 8.3% to $5.22, nearing its one-year low, with trading volume more than …

Co-Diagnostics (NASDAQ: CODX) sees Jane Street disclose 1.7% equity stake

Jane Street Group, LLC and its subsidiaries, Jane Street Capital, LLC and Jane Street Global Trading, LLC, have disclosed a 1.7% equity stake in Co-Diagnostics, Inc. (NASDAQ: CODX). This ownership amounts to 89,240 shares of common stock, held with shared voting and dispositive power. …

Lumexa Imaging Holdings, Inc. expected to post earnings of 16 cents a share - Earnings Preview

Lumexa Imaging Holdings, Inc. is projected to report earnings of 16 cents per share. This information is provided as an earnings preview.

InspireMD Q2 Results: Second Quarter 2026 Earnings Release Date Set

InspireMD, Inc. will release its second quarter 2026 financial results on August 17, 2026, followed by a conference call and webcast at 8:30 a.m. ET. The company, known for its CGuard Prime carotid stent system, will discuss its financial performance and operational updates, including …

Sight Sciences appoints Kashif Rashid as chief legal officer, Jeremy Hayden to step down By Investing.com

Sight Sciences (NASDAQ:SGHT) has announced the appointment of Kashif Rashid as its new chief legal officer and corporate secretary, effective Monday. Rashid brings extensive legal leadership experience from previous roles at Nevro Corp. and other companies. Concurrently, Jeremy Hayden will step down from the …

Sight Sciences appoints Kashif Rashid as chief legal officer, Jeremy Hayden to step down

Sight Sciences, Inc. has announced the appointment of Kashif Rashid as its new chief legal officer and corporate secretary, effective immediately. Rashid brings extensive experience from previous legal leadership roles at several companies, and his compensation package includes an annual base salary of $450,000, …

TACTILE SYSTEMS TECHNOLOGY INC SEC Filing (Aug 10, 2026)

This article reports on TACTILE SYSTEMS TECHNOLOGY INC's SEC Form 144 filing from August 10, 2026. The filing details a proposed sale of securities, including information about the filer, the issuer, and the class of securities to be sold. It also includes an AI-generated …

UFP Technologies (UFPT) chair-linked trust sells 15,695 shares near $318–$320

Jeffrey R. Bailly, Executive Chairman of UFP Technologies (UFPT), reported the sale of 15,695 shares of common stock on August 6-7, 2026, through indirect holdings in a trust. The sales occurred at weighted-average prices ranging from approximately $315.06 to $320.05 per share. After these …

r. Jeffrey Bailly, UFP Technologies executive chairman, sells $5m

R. Jeffrey Bailly, Executive Chairman of UFP Technologies Inc. (NASDAQ:UFPT), recently sold approximately $4.997 million worth of company shares in early August. These transactions occurred on August 6 and 7, 2026, involving 15,695 shares sold at prices between $315.06 and $320.05 per share. The …

Alamar outlines $116M-$120M 2026 revenue outlook while targeting 100+ instruments and $400,000+ pull-through

Earnings Call Insights: Alamar Biosciences (ALMR) Q2 2026 MANAGEMENT VIEW * “Q2 2026 was a strong quarter that reflects the momentum of our business,” said Co-Founder, Chairman & CEO Yuling Luo, highlighting that “Total revenue grew 82% year-over-year,” that “Consumable revenue accounted for 53% …

CeriBell Q2 revenue rises 33%, raises FY26 guidance to $114M-$117M

Hyperfine, Inc. 2026 Q2 - Results - Earnings Call Presentation (NASDAQ:HYPR) 2026-08-10

Medtronic (MDT) Stock Looks Fairly Valued On Cash Flow But Cheap On Earnings

VREX|Varex Imaging Corp|Price:18.450|Chg%:+6.040

UFP Technologies (NASDAQ:UFPT) Chairman Sells 5,013 Shares of Stock

UFP Technologies (NASDAQ:UFPT) Chairman R. Jeffrey Bailly sold 5,013 shares of the company's stock on August 7th, 2026, for approximately $1.59 million, reducing his direct ownership by 27.81%. This follows another sale of 10,682 shares on August 6th. The company's stock traded near its …

R Jeffrey Bailly Sells 10,682 Shares of UFP Technologies (NASDAQ:UFPT) Stock

R. Jeffrey Bailly, Chairman of UFP Technologies (NASDAQ:UFPT), recently sold 10,682 shares for $3.40 million, reducing his stake by 37.21%, and an additional 5,013 shares for $1.59 million. Despite these sales, UFP Technologies stock rose to $325, near its 52-week high, following a strong …

Here's What Key Metrics Tell Us About CeriBell, Inc. (CBLL) Q2 Earnings

Abbott vs. Medtronic: Is Consistent Growth Better Than a Turnaround Story?

Abbott Laboratories (NYSE:ABT) and Medtronic (NYSE:MDT) are both prominent names in the Medtech space. Abbott Laboratories (NYSE:ABT) delivered strong fiscal Q2 2026 results, beating quarterly estimates and raising its annual profit forecast as robust demand for its cancer diagnostics and medical devices businesses helped …

Form 8K Tenon Medical Inc For: 10 August By Investing.com

This article from Investing.com announces the filing of a Form 8K by Tenon Medical Inc for August 10th. The brief piece includes the stock symbol TNON and a minor price change. The core content is a straightforward notification of the SEC filing.

Johnson & Johnson vs. Medtronic: Which Healthcare Stock Is Better Positioned After Earnings?

Johnson & Johnson (NYSE:JNJ) delivered another strong quarter in fiscal Q2 2026, with reported sales increasing 6.6% year over year to $25.31 billion and surpassing analysts' average estimate of around $25.05 billion. Adjusted earnings per share reached $2.90, also exceeding estimates of $2.85. The …

Lucid Diagnostics Inc expected to post a loss of 7 cents a share - Earnings Preview

Lucid Diagnostics Inc is anticipated to report a loss of 7 cents per share in its upcoming earnings announcement. This preview indicates the company's expected financial performance for the period.

CeriBell (NASDAQ:CBLL) Releases Earnings Results

ENvue Medical (FEED) seeks up to $50M via shelf for stock, warrants, units

ENvue Medical (FEED) has filed a shelf registration to offer up to $50 million in common stock, warrants, and units, which may be sold over time. The company's common stock trades on Nasdaq under the symbol FEED, with a recent price of $0.40 per …

Alamar Biosciences FY26 sales guidance beats estimates

Alamar Biosciences (NASDAQ: ALMR) reported strong Q2 2026 results with an 82% revenue surge to $29.4 million, primarily driven by a 147% increase in consumable sales. The company raised its full-year 2026 revenue guidance to $116-$120 million, surpassing analyst estimates. Despite a widening net …

Why QuidelOrtho (QDEL) Stock Is Nosediving

Why QuidelOrtho (QDEL) Stock Is Nosediving What Happened? Shares of healthcare diagnostics company QuidelOrtho (NASDAQ:QDEL) fell 21.3% in the afternoon session after the company slashed its full-year revenue and earnings forecast, overshadowing a second-quarter earnings beat. For the second quarter, QuidelOrtho reported revenue of …

Why iRhythm (IRTC) Stock Is Trading Up Today

Why iRhythm (IRTC) Stock Is Trading Up Today What Happened? Shares of medical technology company iRhythm Technologies (NASDAQ:IRTC) jumped 2% in the afternoon session after the company reported strong second-quarter financial results that surpassed expectations and raised its full-year guidance. The cardiac monitoring company …

Tactile Systems Technology (TCMD) Beats Q2 Earnings and Revenue Estimates

Ceribell forecasts FY 2026 revenue of $114 million-$117 million

Ceribell has issued a revenue guidance for FY 2026, projecting $114 million-$117 million. The company reported a 33% year-over-year revenue increase in Q2 2026 and a year-to-date gross margin of 90% as of June 30, 2026. Ceribell estimates a U.S. market opportunity of $3.5 …

Earnings call transcript: Ceribell tops revenue growth in Q2 2026, shares rise

Ceribell reported strong Q2 2026 results, with revenue growing 33% year-over-year to $28.1 million, surpassing expectations despite an EPS miss. The medical-device company's shares rose as investors focused on its continued expansion in seizure detection, record gross margins of 92%, and advancement of new …